CRISPR Therapeutics Presents Positive Data on Allogeneic CRISPR-based CAR-T Cell Therapies at AACR 2018
pharmaceutical investing Sarepta Therapeutics Announces Fourth Quarter 2017 and Full-Year 2017 Financial Results
Abeona Therapeutics Provides Update from ABO-102 Phase 1/2 MPS IIIA Clinical Trial at the 13th Annual WORLDSymposium™ 2017
Horizon broadens industry-leading gene editing capabilities through extension of key CRISPR license and grant-funded research
Predictive Technology Group, Inc. (PRED) Announces Acquisition of US Patent Application for Method for Treating Patients with Stem Cells "Cleaned" via CRISPR
Abeona Therapeutics Receives EU Orphan Drug Designation for ABO-201 Gene Therapy Program in Juvenile Batten Disease
